Adjuvant immunotherapy for cervical cancer. Two randomized controlled studies using OK-432 or sizofiran.
J Chemother. 1989 Jul;1(4 Suppl):1222-4.
J Chemother. 1989.
PMID: 16312843
No abstract available.